BitFrontier Capital Holdings, Inc., doing business as UNLOCKD Inc., announced preliminary operating results for its recently acquired subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA, showing a 76% month-over-month revenue increase in May 2026. The company reported preliminary April revenue of approximately $12,670, which rose to approximately $22,344 in May, reflecting strong early traction under UNLOCKD ownership.
UNLOCKD completed the acquisition of Ancient Extracts in mid-May, meaning the reported May revenue represents only a partial month of operations under the new ownership. On June 2, 2026, Ancient Extracts also received a purchase order representing approximately $58,823 in retail product value, with an order total of approximately $29,411 under wholesale pricing terms. All financial figures disclosed are preliminary, unaudited, and subject to further review.
“We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing,” stated John P. Gorst, Chief Executive Officer of UNLOCKD. “The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition. Our focus remains on disciplined execution, strengthening operations, expanding distribution, and creating long-term shareholder value through sustainable growth.”
Ancient Extracts USA offers a portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha products, shilajit, and wellness-focused consumer goods under the brand philosophy of “Ancient Remedies for Modern Life.” The company believes the brand is well-positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, and botanical wellness products.
Management believes Ancient Extracts provides UNLOCKD with a capital-efficient operating foundation to pursue additional commercialization opportunities, strategic partnerships, product innovation, and long-term expansion. Dr. Jordan P. Balencic, Chairman and Chief Science Officer of UNLOCKD, commented: “When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth. While it remains early in the integration process, the initial operating results and commercial traction we are seeing continue to reinforce our conviction in the opportunity.”
Dr. Balencic added: “Our objective is straightforward: grow revenue, expand distribution, strengthen our portfolio of wellness assets, and execute with discipline. We believe Ancient Extracts provides a strong operating nucleus capable of supporting broader growth initiatives across wellness, functional nutrition, cognitive health, and human optimization.”
Separately, UNLOCKD announced that its UNLOCKD Technologies division has begun preliminary planning for future consumer health technology opportunities. Management has initiated early-stage evaluation of point-of-care testing concepts and engaged in preliminary discussions with developers, suppliers, and potential strategic partners. These initiatives remain in the conceptual and planning stages, and the company expects to pursue dedicated financing for such initiatives rather than using capital intended for current operations. No assurances can be provided regarding timing, financing, development, regulatory pathway, or commercial success of any future technology initiatives.
For more information, visit www.unlockdinc.com or follow @BFCHco on X for verified company updates.
